Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
4 Pogledi
• 08/09/23
0
0
Ugraditi
administrator
Pretplatnici
Dr. Prince, Professor, The University of Melbourne and Monash University, talks about the outcomes of the ALCANZA study in CD30-expressing CTCL
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari